Category
Investors may want to keep an eye on a potential biotech M&A boom. In recent days, Pfizer announced it’s paying $11.6 billion for Biohaven to tap into the migraine market. “Through the deal, Pfizer will gain Biohaven’s migraine drug Nurtec, a potential...
Electricity shortages could be common this summer. In fact, as noted by The Wall Street Journal: “From California to Texas to Indiana, electric-grid operators are warning that power-generating capacity is struggling to keep up with demand, a gap that could lead to...
Russian President Vladimir Putin tried to justify Moscow's invasion of Ukraine during "Victory Day," the country's most important national event. He said that the West was planning to invade their territory, including Crimea but didn't provide any evidence. Ahead of...
